Well, we finally got the news everyone was kind of half-expecting (and half-hoping wouldn't be true for a long time to come).

NEW YORK, NY / ACCESS Newswire / May 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Capricor Therapeutics, Inc. ("Capricor Therapeutics, Inc.") (NASDAQ:CAPR) concerning possible violations of federal securities laws. Capricor issued a press release on May 5, 2025, announcing that after "the completion of a mid-cycle review meeting with the U.S. Food and Drug Administration (FDA) for the Company's Biologics License Application (BLA) seeking full approval for deramiocel, an investigational cell therapy, as a treatment for patients diagnosed with Duchenne muscular dystrophy (DMD) cardiomyopathy", the FDA had "confirmed its intent to hold …

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of T-Mobile US, Inc. (“T-Mobile” or the “Company”) (NASDAQ: TMUS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, NY / ACCESS Newswire / May 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of PTC Therapeutics, Inc. ("PTC Therapeutics, Inc.") (NASDAQ:PTCT) concerning possible violations of federal securities laws. PTC issued a press release on May 5, 2025, "announc[ing] results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in Stage 2 and Stage 3 Huntington's disease (HD) patients.

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of Indiana on behalf of all persons or entities who purchased or otherwise acquired Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) securities between April 18, 2024 and October 16, 2024, inclusive (the “Class Period”). The lawsuit seeks to recover damages for the Company's investors under the federal securities laws.

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE: ATNM) of a class action securities lawsuit.

Fennec Pharmaceuticals Inc. (NASDAQ:FENC ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Robert Andrade - Chief Financial Officer Jeff Hackman - Chief Executive Officer and Director Conference Call Participants Chase Knickerbocker - Craig Hallum Sudan Loganathan - Stevens Michael Okunewitch - Maxim Group Raghuram Selvaraju - H.C. Wainwright Operator Good morning, ladies and gentlemen.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025. West describes itself as a “medical supplies company specializing in packaging components, containment solutions, and delivery systems for injectable drugs.” For more information, submit a form, email attorney Phillip Kim, or give u.

STAMFORD, Conn.--(BUSINESS WIRE)-- #AI--Bread Financial, Brink's, Polaris, U.S. Bank, Moderna, Takeda, Carnival, Wayfair, Pfizer and KeyBank will join the ISG AI Impact Summit, June 3-4.

We're winding down earnings season, and the old Wall Street adage that “earnings drive stock prices” continues to prove true.

Hertz (NYSE:HTZ) shares plunged more than 14% after the car rental agency reported a wider-than-expected loss for the first quarter. The company posted an adjusted loss of $1.12 per share, compared to analysts' expectations of a $0.95 loss.

One of the world's most well-known stock market indexes, the S&P 500, will soon look a little different. That's because its roster of 500 companies is getting a shakeup, which will see the cryptocurrency exchange Coinbase Global join the index.

Best known for shorting stocks like GameStop, Citron Research's Andrew Left also shares long calls on stocks that are undervalued by Wall Street.

BALTIMORE--(BUSINESS WIRE)--Sinclair today announced CHARGE, the top destination for action-packed crime procedurals, will launch CHARGECON '25, a two-day televised celebration of the iconic police procedurals CSI: NY and CSI: Miami with exclusive interviews with Anthony E. Zuiker, the creator of the CSI franchise. CHARGECON will offer fans a rare look into the making of the series as Zuiker, acclaimed television writer, producer and author, reflects on his favorite episodes and shares inside s.

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of FTI Consulting, Inc. (“FTI” or the “Company”) (NYSE: FCN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Wabash National Corporation (“Wabash” or the “Company”) (NYSE: WNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Shareholders Must Hold Shares in Multiples of Eight by Market Close on May 27, 2025 to Avoid Fractional Share Cash-Out

Shares of Rivian Automotive (NASDAQ:RIVN) gained 1.37% through a.m.

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or the “Company”) (NYSE: BLCO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.